I’m part of the Leerink Partners equity research team. Marty Huber, CEO, Mersana: It’s a Jonathan Chang, Equity Research, Leerink Partners: pleasure to host the management team of Mersana. We have ...

I’m part of the Leerink Partners equity research team. Marty Huber, CEO, Mersana: It’s a Jonathan Chang, Equity Research, Leerink Partners: pleasure to host the management team of Mersana.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Mersana Therapeutics (MRSN – Research Report), Revelation Biosciences (REVB – Research Report ...

CAMBRIDGE, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...

the Tesla (TSLA.O), opens new tab CEO said on Monday in an interview with Fox Business. His remarks followed Tesla losing $130 billion in stock market value in a broad selloff on Wall Street that ...

Nissan said Tuesday that Ivan Espinosa, its chief planning officer, would take the helm from April 1, ending weeks of speculation over who will succeed Makoto Uchida as leader of the troubled ...

Another billionaire has entered the rocket race. Former Google CEO Eric Schmidt has provided "substantial financial backing" and has become the CEO of rocket startup Relativity Space, its outgoing ...

The 3rd Next-Generation Conjugates Summit (Boston | February 26-28, 2024) is the only event dedicated to showcasing conjugate drugs with novel payloads and formats, providing unrivalled access to ...